Proinsulin C-peptide reduces diabetes-induced glomerular hyperfiltration via efferent arteriole dilation and inhibition of tubular sodium reabsorption

American Journal of Physiology - Renal Physiology

Volumn 297, Issue 5, 2009, Pages

  Nordquist, Lina ^a   Brown, Russell ^a,b   Fasching, Angelica ^a   Persson, Patrik ^a   Palm, Fredrik ^a,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b MONASH UNIVERSITY   (Australia)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes mellitus; Oxygen consumption; Sodium excretion

Indexed keywords

C PEPTIDE; SODIUM ION;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DIABETES MELLITUS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; KIDNEY TUBULE ABSORPTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SODIUM ABSORPTION; SODIUM TRANSPORT; ULTRAFILTRATION;

EID: 70350705959     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00228.2009     Document Type: Article

References (60)

1. 2 adenosine receptors dilates cortical efferent arterioles in mouse. Kidney Int 75: 793-799, 2009.
2. Al-Rasheed NM, Meakin F, Royal EL, Lewington AJ, Brown J, Willars GB, Brunskill NJ. Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells. Diabetologia 47: 987-997, 2004. (Pubitemid 38918157)
3. Brenner BM, Troy JL. Postglomerular vascular protein concentration: evidence for a causal role in governing fluid reabsorption and glomerulotublar balance by the renal proximal tubule. J Clin Invest 50: 336-349, 1971.
4. Brodwall EK, Laake H. The relation between oxygen consumption and transport of sodium in the human kidney. Scand J Clin Lab Invest 16: 281-286, 1964.
5. +-ATPase in control and streptozotocin-induced diabetic mice by G-protein acting toxins and phorbol esters. Eur J Pharmacol 225: 275-279, 1992.
6. Cohen RA, MacGregor LC, Spokes KC, Silva P, Epstein FH. Effect of myo-inositol on renal Na-K-ATPase in experimental diabetes. Metabolism 39: 1026-1032, 1990. (Pubitemid 20351259)
7. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329: 977-986, 1993.
8. Djemli-Shipkolye A, Gallice P, Coste T, Jannot MF, Tsimaratos M, Raccah D, Vague P. The effects ex vivo and in vitro of insulin and C-peptide on Na/K adenosine triphosphatase activity in red blood cell membranes of type 1 diabetic patients. Metabolism 49: 868-872, 2000. (Pubitemid 30483439)
9. dos Santos EA, Li LP, Ji L, Prasad PV. Early changes with diabetes in renal medullary hemodynamics as evaluated by fiberoptic probes and BOLD magnetic resonance imaging. Invest Radiol 42: 157-162, 2007.
10. 1 adenosine receptors augments diabetic hyperfiltration and glomerular injury. J Am Soc Nephrol 19: 722-730, 2008.
11. 2+ channels in afferent and efferent arterioles. Am J Physiol Renal Physiol 290: F873-F879, 2006.
12. Feraille E, Barlet-Bas C, Cheval L, Rousselot M, Carranza ML, Dreher D, Arystarkhova E, Doucet A, Favre H. Presence of two isoforms of Na,K-ATPase with different pharmacological and immunological properties in the rat kidney. Pflügers Arch 430: 205-212, 1995.
13. +-ATPase activity in diabetes mellitus type I. Clin Sci (Lond) 98: 283-290, 2000.
14. Forst T, Kunt T, Pfutzner A, Beyer J, Wahren J. New aspects on biological activity of C-peptide in IDDM patients. Exp Clin Endocrinol Diabetes 106: 270-276, 1998. (Pubitemid 28457006)
15. 2+ channel subtypes and pharmacology in the kidney. Circ Res 100: 342-353, 2007.
16. Huang DY, Richter K, Breidenbach A, Vallon V. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study. Naunyn Schmiedebergs Arch Pharmacol 365: 67-73, 2002. (Pubitemid 34045241)
17. Ido Y, Vindigni A, Chang K, Stramm L, Chance R, Heath WF, DiMarchi RD, Di Cera E, Williamson JR. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 277: 563-566, 1997. (Pubitemid 27369004)
18. Izuhara Y, Nangaku M, Inagi R, Tominaga N, Aizawa T, Kurokawa K, van Ypersele de Strihou C, Miyata T. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 16: 3631-3641, 2005. (Pubitemid 46211284)
19. Johansson BL, Borg K, Fernqvist-Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med 17: 181-189, 2000. (Pubitemid 30212289)
20. Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 35: 121-128, 1992.
21. Kamikawa A, Ishii T, Shimada K, Makondo K, Inanami O, Sakane N, Yoshida T, Saito M, Kimura K. Proinsulin C-peptide abrogates type-1 diabetes-induced increase of renal endothelial nitric oxide synthase in rats. Diabetes Metab Res Rev 24: 331-338, 2008. (Pubitemid 351802799)
22. Karlsen FM, Holstein-Rathlou NH, Leyssac PP. A re-evaluation of the determinants of glomerular filtration rate. Acta Physiol Scand 155: 335-350, 1995.
23. Katavetin P, Miyata T, Inagi R, Tanaka T, Sassa R, Ingelfinger JR, Fujita T, Nangaku M. High glucose blunts vascular endothelial growth factor response to hypoxia via the oxidative stress-regulated hypoxia-inducible factor/hypoxia-responsible element pathway. J Am Soc Nephrol 17: 1405-1413, 2006. (Pubitemid 43673421)
24. Katz AI, Epstein FH. The role of sodium-potassium-activated adenosine triphosphatase in the reabsorption of sodium by the kidney. J Clin Invest 46: 1999-2011, 1967.
25. Kim SM, Mizel D, Huang YG, Briggs JP, Schnermann J. Adenosine as a mediator of macula densa-dependent inhibition of renin secretion. Am J Physiol Renal Physiol 290: F1016-F1023, 2006. (Pubitemid 43724900)
26. Kitamura T, Kimura K, Makondo K, Furuya DT, Suzuki M, Yoshida T, Saito M. Proinsulin C-peptide increases nitric oxide production by enhancing mitogen-activated protein-kinase-dependent transcription of endothelial nitric oxide synthase in aortic endothelial cells of Wistar rats. Diabetologia 46: 1698-1705, 2003. (Pubitemid 38005332)
27. Korner A, Eklof AC, Celsi G, Aperia A. Increased renal metabolism in diabetes. Mechanism and functional implications. Diabetes 43: 629-633, 1994. (Pubitemid 24138773)
28. Ku DD, Sellers BM, Meezan E. Development of renal hypertrophy and increased renal Na,K-ATPase in streptozotocin-diabetic rats. Endocrinology 119: 672-679, 1986. (Pubitemid 16048823)
29. Larsen EH, Mobjerg N, Sorensen JN. Fluid transport and ion fluxes in mammalian kidney proximal tubule: a model analysis of isotonic transport. Acta Physiol (Oxf) 187: 177-189, 2006. (Pubitemid 43828775)
30. Leyssac PP. Dependence of glomerular filtration rate on proximal tubular reabsorption of salt. Acta Physiol Scand 58: 236-242, 1963.
31. Marin-Grez M, Fleming JT, Steinhausen M. Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney. Nature 324: 473-476, 1986. (Pubitemid 17184166)
32. 1 receptor antagonist on hemodynamic and tubular function in the kidney. Kidney Blood Press Res 30: 388-399, 2007.
33. Nath KA, Kren SM, Hostetter TH. Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction. J Clin Invest 78: 1199-1205, 1986.
34. +)-ATPase isozymes for cardioactive steroids, role of lactone ring, sugar moiety and KCl concentration. Biochem Pharmacol 40: 2611-2616, 1990.
35. Nordquist L, Lai EY, Sjoquist M, Patzak A, Persson AE. Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism. Am J Physiol Regul Integr Comp Physiol 294: R836-R841, 2008. (Pubitemid 351346960)
36. Nordquist L, Moe E, Sjoquist M. The C-peptide fragment EVARQ reduces glomerular hyperfiltration in streptozotocin-induced diabetic rats. Diabetes Metab Res Rev 23: 400-405, 2007. (Pubitemid 47091244)
37. +-ATPase activity in synergism with neuropeptide Y. Diabetologia 39: 199-205, 1996.
38. Ott CE, Marchand GR, Diaz-Buxo JA, Knox FG. Determinants of glomerular filtration rate in the dog. Am J Physiol 231: 235-239, 1976.
39. Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia 46: 1153-1160, 2003. (Pubitemid 37041246)
40. Palm F, Hansell P, Ronquist G, Waldenstrom A, Liss P, Carlsson PO. Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats. Diabetologia 47: 1223-1231, 2004. (Pubitemid 39093318)
41. Persson AE, Gushwa LC, Blantz RC. Feedback pressure-flow responses in normal and angiotensin-prostaglandin-blocked rats. Am J Physiol Renal Fluid Electrolyte Physiol 247: F925-F931, 1984.
42. Rebsomen L, Pitel S, Boubred F, Buffat C, Feuerstein JM, Raccah D, Vague P, Tsimaratos M. C-peptide replacement improves weight gain and renal function in diabetic rats. Diabetes Metab 32: 223-228, 2006. (Pubitemid 43966745)
43. Ren YL, Garvin JL, Ito S, Carretero OA. Role of neuronal nitric oxide synthase in the macula densa. Kidney Int 60: 1676-1683, 2001. (Pubitemid 32999971)
44. Ries M, Basseau F, Tyndal B, Jones R, Deminiere C, Catargi B, Combe C, Moonen CW, Grenier N. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging 17: 104-113, 2003.
45. Rosenberger C, Khamaisi M, Abassi Z, Shilo V, Weksler-Zangen S, Goldfarb M, Shina A, Zibertrest F, Eckardt KU, Rosen S, Heyman SN. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int 73: 34-42, 2008. (Pubitemid 350273633)
46. 1-receptor deficient mice lacking the tubuloglomerular feedback mechanism. Acta Physiol (Oxf) 190: 253-259, 2007.
47. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Ekberg K, Isaksson B, Eriksson L, Wahren J, Sjoquist M. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats. Nephrol Dial Transplant 20: 532-538, 2005. (Pubitemid 40378421)
48. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 60: 1258-1265, 2001. (Pubitemid 32960021)
49. Samnegard B, Jacobson SH, Johansson BL, Ekberg K, Isaksson B, Wahren J, Sjoquist M. C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant 19: 1385-1391, 2004. (Pubitemid 38786728)
50. Scherzer P, Nachliel I, Bar-On H, Popovtzer MM, Ziv E. Renal Na-K-ATPase hyperactivity in diabetic Psammomys obesus is related to glomerular hyperfiltration but is insulin-independent. J Endocrinol 167: 347-354, 2000. (Pubitemid 30836626)
51. Sjoquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 54: 758-764, 1998. (Pubitemid 28397393)
52. Thaysen JH, Lassen NA, Munck O. Sodium transport and oxygen consumption in the mammalian kidney. Nature 190: 919-921, 1961.
53. Thomson SC, Vallon V, Blantz RC. Kidney function in early diabetes: the tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 286: F8-F15, 2004. (Pubitemid 38045037)
54. Vallon V, Richter K, Blantz RC, Thomson S, Osswald H. Glomerular hyperfiltration in experimental diabetes mellitus: potential role of tubular reabsorption. J Am Soc Nephrol 10: 2569-2576, 1999.
55. 1 receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus. Nephron Physiol 111: p30-p38, 2009.
56. Vervoort G, Veldman B, Berden JH, Smits P, Wetzels JF. Glomerular hyperfiltration in type 1 diabetes mellitus results from primary changes in proximal tubular sodium handling without changes in volume expansion. Eur J Clin Invest 35: 330-336, 2005. (Pubitemid 40691281)
57. Wald H, Scherzer P, Popovtzer MM. Enhanced renal tubular ouabain-sensitive ATPase in streptozotocin diabetes mellitus. Am J Physiol Renal Fluid Electrolyte Physiol 251: F164-F170, 1986. (Pubitemid 16013518)
58. +-ATPase in diabetes mellitus: relationship to metabolic abnormality. Am J Physiol Endocrinol Metab 265: E96-E101, 1993.
59. Wojcikowski C, Maier V, Dominiak K, Fussganger R, Pfeiffer EF. Effects of synthetic rat C-peptide in normal and diabetic rats. Diabetologia 25: 288-290, 1983.
60. +-ATPase via activation of ERK1/2 MAP kinases in human renal tubular cells. Cell Mol Life Sci 61: 2782-2790, 2004.